Pangenomic Health Inc.
NARA
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 531.80K | 542.40K | 481.40K | 424.90K | 188.80K |
| Gross Profit | -531.80K | -542.40K | -481.40K | -424.90K | -188.80K |
| SG&A Expenses | 1.57M | 527.00K | 448.20K | 389.00K | 606.60K |
| Depreciation & Amortization | 400.00 | 1.80K | 4.00K | 6.20K | 8.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.10M | 1.07M | 938.60K | 807.20K | 815.00K |
| Operating Income | -2.10M | -1.07M | -938.60K | -807.20K | -815.00K |
| Income Before Tax | -2.45M | -1.31M | -2.89M | -2.77M | -2.57M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.45 | -1.31 | -2.89 | -2.77 | -2.57 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.45M | -1.31M | -2.89M | -2.77M | -2.57M |
| EBIT | -2.10M | -1.07M | -938.60K | -807.20K | -815.00K |
| EBITDA | -2.10M | -1.07M | -934.50K | -800.90K | -806.50K |
| EPS Basic | -0.25 | -0.19 | -0.51 | -0.54 | -0.63 |
| Normalized Basic EPS | -0.14 | -0.10 | -0.11 | -0.13 | -0.21 |
| EPS Diluted | -0.25 | -0.19 | -0.51 | -0.54 | -0.63 |
| Normalized Diluted EPS | -0.14 | -0.10 | -0.11 | -0.13 | -0.21 |
| Average Basic Shares Outstanding | 42.12M | 32.94M | 24.61M | 19.47M | 16.14M |
| Average Diluted Shares Outstanding | 42.12M | 32.94M | 24.61M | 19.47M | 16.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |